A 600 kb Deletion Syndrome at 16p11.2 Leads to Energy Imbalance and Neuropsychiatric Disorders

View/ Open
Author
Zufferey, Flore
Sherr, Elliott H
Beckmann, Noam D
Maillard, Anne M
Hippolyte, Loyse
Macé, Aurélien
Ferrari, Carina
Kutalik, Zoltán
Andrieux, Joris
Aylward, Elizabeth
Barker, Mandy
Bernier, Raphael
Bouquillon, Sonia
Conus, Philippe
Delobel, Bruno
Faucett, W Andrew
Goin-Kochel, Robin P
Grant, Ellen
Harewood, Louise
Hunter, Jill V
Lebon, Sébastien
Ledbetter, David H
Martin, Christa Lese
Männik, Katrin
Martinet, Danielle
Mukherjee, Pratik
Ramocki, Melissa B
Steinman, Kyle J
Tjernagel, Jennifer
Spiro, John E
Reymond, Alexandre
Beckmann, Jacques S
Chung, Wendy K
Jacquemont, Sébastien
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1136/jmedgenet-2012-101203Metadata
Show full item recordCitation
Zufferey, Flore, Elliott H Sherr, Noam D Beckmann, Ellen Hanson, Anne M Maillard, Loyse Hippolyte, Aurélien Macé, et al. 2012. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. Journal of Medical Genetics 49(10): 660-668.Abstract
Background: The recurrent ∼600 kb 16p11.2 BP4-BP5 deletion is among the most frequent known genetic aetiologies of autism spectrum disorder (ASD) and related neurodevelopmental disorders. Objective: To define the medical, neuropsychological, and behavioural phenotypes in carriers of this deletion. Methods: We collected clinical data on 285 deletion carriers and performed detailed evaluations on 72 carriers and 68 intrafamilial non-carrier controls. Results: When compared to intrafamilial controls, full scale intelligence quotient (FSIQ) is two standard deviations lower in carriers, and there is no difference between carriers referred for neurodevelopmental disorders and carriers identified through cascade family testing. Verbal IQ (mean 74) is lower than non-verbal IQ (mean 83) and a majority of carriers require speech therapy. Over 80% of individuals exhibit psychiatric disorders including ASD, which is present in 15% of the paediatric carriers. Increase in head circumference (HC) during infancy is similar to the HC and brain growth patterns observed in idiopathic ASD. Obesity, a major comorbidity present in 50% of the carriers by the age of 7 years, does not correlate with FSIQ or any behavioural trait. Seizures are present in 24% of carriers and occur independently of other symptoms. Malformations are infrequently found, confirming only a few of the previously reported associations. Conclusions: The 16p11.2 deletion impacts in a quantitative and independent manner FSIQ, behaviour and body mass index, possibly through direct influences on neural circuitry. Although non-specific, these features are clinically significant and reproducible. Lastly, this study demonstrates the necessity of studying large patient cohorts ascertained through multiple methods to characterise the clinical consequences of rare variants involved in common diseases.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494011/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:10589806
Collections
- HMS Scholarly Articles [17875]
Contact administrator regarding this item (to report mistakes or request changes)